Evidence map›Paper›PMID 36404359›Full record

SynthesisLasers in medical science2022

Photobiomodulation therapy in mood disorders: a systematic review.

Katayoon Montazeri, Mohammad Farhadi, Reza Fekrazad, Samira Chaibakhsh, Saeid Mahmoudian

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Lasers in medical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Katayoon MontazeriENT and Head & Neck Research Center, The Five Senses Health Institute, School of Medicine, Iran University of medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0003-1237-6913
Mohammad FarhadiENT and Head & Neck Research Center, The Five Senses Health Institute, School of Medicine, Iran University of medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0001-6303-1750
Reza FekrazadRadiation Sciences Research Center, Laser Research Center in Medical Sciences, AJA University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0001-5188-8829
Samira ChaibakhshEye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran. smr.chaibakhsh@gmail.com.ORCID http://orcid.org/0000-0001-9462-118X
Saeid MahmoudianENT and Head & Neck Research Center, The Five Senses Health Institute, School of Medicine, Iran University of medical Sciences, Tehran, Iran. mahmoudian.s@iums.ac.ir.ORCID http://orcid.org/0000-0002-6908-7605
Iran University of Medical Sciences · IRAja University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mood disorders are common, debilitating and impose a high-cost burden on society. Side effects and resistance to psychiatric drugs justify finding new treatment methods. Photobiomodulation therapy (PBMT) uses photons of light to repair, modulate and improve the function of target tissue. The purpose of this study is to systematically review the use of PBMT for the treatment of mood disorders and to identify the useful parameters of PBMT, the level of evidence of its effectiveness, and the degree of its practical recommendation. "Google scholar," "Pub Med," "Scopus," and "Science direct" online databases were searched based on Preferred Reporting Items for Systematic Reviews and meta-analyses (PRISMA) guidelines. The human or animal studies written in English and published from January 2009 to August 2021 were included. Sixteen studies, which included four randomized controlled trials (RCTs), met the inclusion criteria. Infrared wavelength ranges from 800 to 830 nm, power density of 250 mW/cm

Indexed as

Low-Level Light TherapyAnimalsHumansPhotonsRisk AssessmentLaser therapyLow-level laser therapyLow-level light therapyLow power laser therapyMood disordersPhotobiomodulation therapy

Identifiers

PMID36404359
OpenAlexW4309510765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.